Disparities in Surgical Oncologic Care
Tanay Sorathia, BS
Graduate Student
Columbia University, Mailman School of Public Health, Department of Epidemiology, United States
Tanay Sorathia, BS
Graduate Student
Columbia University, Mailman School of Public Health, Department of Epidemiology, United States
Tanay Sorathia, BS
Graduate Student
Columbia University, Mailman School of Public Health, Department of Epidemiology, United States
Esther Jean-Baptiste, MPH
NTRO Research Study Manager
Moffitt Cancer Center, Department of Cancer Epidemiology, United States
Amanda Bloomer, MA, CHDA
Research Project Specialist Sr.
Moffitt Cancer Center, Department of Cancer Epidemiology, United States
Gazelle Rouhani, MPH
Doctoral Student
University of Miami Miller School of Medicine, Department of Epidemiology and Public Health, United States
Gillian Trujillo, BS
Supervisor
Moffitt Cancer Center, Non-therapeutic Research Office, United States
Rachel Carmella, MPH
Research Services Project Coordinator
Moffitt Cancer Center, Non-therapeutic Research Office, United States
Julaxis Love, BS
Research Data Coordinator
Moffitt Cancer Center, Non-therapeutic Research Office, United States
Maria Gomez, MPH
Research Data Analyst
Moffitt Cancer Center, Non-therapeutic Research Office, United States
Cornelia M. Ulrich, MS, PhD
Chief Scientific Officer and Executive Director
Huntsman Cancer Institute, Department of Population Health Sciences, United States
Christopher I. Li, MD, PhD
Research Full Professor
Fred Hutchinson Cancer Research Center, Public Health Sciences Division, United States
Biljana Gigic, PhD
Scientist
University of Heidelberg, Department of General, Visceral and Transplantation Surgery, United States
Jane C. Figueiredo, PhD
Associate Professor
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Department of Medicine, United States
David Shibata, MD, FACS, FSSO, FASCRS
Professor and Chair of the Department of Surgery
University of Tennessee Health Science Center, Department of Surgery
Memphis, TN, United States
Adetunji T. Toriola, MD, PhD, MPH
Associate Professor
Washington University School of Medicine in St. Louis, Department of Surgery, United States
Seth I. Felder, MD
Colon and Rectum Surgeon
H. Lee Moffitt Cancer Center and Research Institute, United States
Erin M. Siegel, PhD, MPH
Principal Investigator
Moffitt Cancer Center, Department of Cancer Epidemiology and Department of Gastrointestinal Oncology, United States
Amalia Stefanou, MD
Surgical Oncologist
Moffitt Cancer Center, Department of Gastrointestinal Oncology, United States
The study sample consisted of 101 patients, of which 45.5% (n = 45) had a high ADI, 59.6% (n = 59) were male, 48.5% (n = 48) had typical onset of cancer (between the ages 50 and 64), and 89.9% (n = 89) were non-Hispanic white. 56.4% (n = 57) of the patients received fragmented care. In univariate analysis, patients with fragmented care had different insurance types compared to those without fragmented care (p < 0.01). In contrast, age, gender, BMI, race/ethnicity, marital status, cancer stage, comorbidities, smoke status, and cancer type were not significantly associated with fragmented care. After adjusting for the covariates used in the univariate analysis, the odds of receiving fragmented care for patients with a high ADI was 0.34 (95% CI: 0.14 - 1.09; p = 0.07), indicating a trend that those who reside in impoverished areas are less likely to receive fragmented care.
Conclusions: Fragmented care is prominent among rectal cancer patients who receive multimodal treatment. Our study identified a trend between ADI and fragmented care. Insurance status was found to be associated with fragmented care, which may indicate that insurance could impact continuous care for rectal cancer treatment. Factors including distance traveled to a facility and a larger, diverse sample should be considered in future analyses incorporating multi-site data to test the association between ADI and the receipt of fragmented care.